Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Cash from Financing Activities (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Cash from Financing Activities over the past 16 years, most recently at -$402000.0 for Q2 2025.

  • For Q2 2025, Cash from Financing Activities rose 34.53% year-over-year to -$402000.0; the TTM value through May 2025 reached $6.4 million, down 14.45%, while the annual FY2025 figure was $6.4 million, 14.45% down from the prior year.
  • Cash from Financing Activities for Q2 2025 was -$402000.0 at Lifecore Biomedical, Inc. \De\, up from -$6.8 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $24.6 million in Q2 2023 and troughed at -$47.1 million in Q1 2022.
  • A 5-year average of -$378166.7 and a median of $2.7 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 352.51% in 2022 and later soared 611.23% in 2024.
  • Year by year, Cash from Financing Activities stood at $9.9 million in 2021, then dropped by 10.82% to $8.8 million in 2022, then tumbled by 127.79% to -$2.4 million in 2023, then soared by 611.23% to $12.5 million in 2024, then crashed by 103.21% to -$402000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for LFCR at -$402000.0 in Q2 2025, -$6.8 million in Q1 2025, and $12.5 million in Q4 2024.